Benchmark Reiterates Buy on Harvard Bioscience, Maintains $4 Price Target
Benchmark analyst Kenneth Bruce reiterates Harvard Bioscience (NASDAQ:HBIO) with a Buy and maintains $4 price target.
Earnings Scheduled For March 9, 2023
Companies Reporting Before The Bell
• Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.
Harvard Bioscience Announces CFO Transition, Michael Rossi To Retire Effective December 31; Appointed Jennifer Cote, The Company’s Vice President Of Global Finance, As Its Interim CFO And Treasurer
Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company") today announced the resignation of Michael Rossi, the Company's chief financial officer and treasurer, effective December 31, 2022. The Company has
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell
• Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
Earnings Preview: Harvard Bioscience
Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement.
Analysts estimate that Harvard Bioscience will report an earnings per share (EPS) of $0.07.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 574 stocks hit new 52-week lows.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million.
